AGIOS PHARMACEUTICALS, INC. Available-for-sale Securities
AGIOS PHARMACEUTICALS, INC. (AGIO) had Available-for-sale Securities of $508.99 million as of 2017-09-30, per its 10-Q filed 2017-11-01.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2017-11-01
- 2017-09-30: Available-for-sale Securities $508.99M.
- 2017-06-30: Available-for-sale Securities $577.22M.
- 2016-12-31: Available-for-sale Securities $412.81M; Available-for-sale Securities as first filed $564.06M.
- 2016-09-30: Available-for-sale Securities $613.87M.
| Period end | Available-for-sale Securities | Available-for-sale Securities as first filed |
|---|---|---|
| 2017-09-30 | $508.99M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $577.22M 10-Q · filed 2017-08-08 | |
| 2016-12-31 | $412.81M 10-Q · filed 2017-11-01 | $564.06M 10-K · filed 2017-02-16 |
| 2016-09-30 | $613.87M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $503.81M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $343.56M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $363.48M 10-K · filed 2017-02-16 | |
| 2015-09-30 | $327.94M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $361.50M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $404.71M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $465.79M 10-K · filed 2016-02-26 | $453.42M 10-K · filed 2015-02-24 |
| 2014-09-30 | $167.84M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $152.86M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $134.44M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $122.33M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $102.36M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $21.79M 10-Q · filed 2013-09-05 | |
| 2012-12-31 | $36.68M 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |